Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-002112

CEO and CFO bought 2,900 shares at $27.54 ($79,866)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-12 Purchase : show line 1 in the form +2,900 $27.54 $79,866 5,602,302 D
Open-market purchases · 2,900 sh · avg $27.54 · $79,866
Loading xslF345X05/ownership.xml…